Αρχική World News How My Advanced Colorectal Cancer Diagnosis Led Me to Patient Advocacy

How My Advanced Colorectal Cancer Diagnosis Led Me to Patient Advocacy

Mr. Wilson is a colorectal cancer survivor and patient advocate who lives in Denver, Colorado.

The first half of 2016 was arguably the most exciting of my life. My wife, Jaione, and I had decided to leave the United Kingdom and move with our 2 children, Andrew, then 14, and Alba, then 10, to Denver, Colorado, where I was taking on a leadership role in corporate affairs for a brewery company. By the beginning of summer, I noticed I was losing a bit of weight and was leaner than usual, but the weight loss wasn’t dramatic enough to be concerning. I assumed it was due to the frenzy of relocating our family to a new country and settling into our new life. But soon after, I started noticing specks of blood in my stool, and that set off an ominous alarm bell in my head.

My mother had been diagnosed with colorectal cancer when she was 56 and died 3 years later. I was now 48. I had been screened for colorectal cancer at age 46 via a guaiac-based fecal occult blood test. In England, to qualify for a colonoscopy, even if you are at high risk for colon cancer, you have to be 55 or older or have 2 first-degree relatives who died of the disease. The blood test was found to be negative for colon cancer. I’m now convinced the test was inaccurate.

The blood in my stool immediately sent me to a primary care physician. Before I could even meet with him, after taking my medical history and noting my current symptoms, the nurse practitioner sent me for an appointment with a gastroenterologist and a colonoscopy. After that, everything changed.

I awoke from the anesthesia to the fearsome words, “We have found a mass, and you will require surgery.” I felt like the blood was draining from my body and remember thinking, “This is cancer, and I could die.” A computed tomography (CT) scan of my body found more bad news. I had multiple tumors and lesions in my liver. The diagnosis was stage IV colorectal cancer, and at that moment, life just stopped.

The oncologist I met with suggested I have surgery to remove the mass in my colon, followed by an aggressive chemotherapy regimen of fluorouracil, leucovorin, and oxaliplatin (FOLFOX) to eliminate the tumors in my liver. And because the metastatic cancer is RAS wild-type, the monoclonal antibody panitumumab (Vectibix) was added to the mix.

The very next event changed my life.

Offering patient support

My boss offered to call his friend who worked at the Translational Genomics Research Institute in Phoenix, Arizona, to ask his advice. A few hours later, I received a call from him. He started the conversation by saying that although he couldn’t offer me a groundbreaking treatment that would cure my cancer, he had faith in the standard of care I would be receiving and believed the therapy would be successful in putting me in remission. But his next words seared in my memory and have become the encouraging words I now use in my patient advocacy: “If the treatment doesn’t work, we will be here for you.” Those words gave me the hope I needed to move forward and have propelled me to become a patient advocate.

He was right. The initial treatment was successful in eliminating the cancer in my liver, and maintenance therapy with panitumumab has kept the cancer from returning. Although I haven’t been declared cured of colorectal cancer, there is no evidence of the disease in my body. I don’t know how long I’ll have to be on maintenance panitumumab, but perhaps it will be for the rest of my life. I once asked a physician about the timeframe for continuing maintenance therapy, and she said, “You never want to turn your back on metastatic cancer.” Her words have stuck with me.

When I got the diagnosis, my oncologist didn’t offer a prognosis, and I didn’t ask for one. The only question I asked was, “Can this cancer be treated?” Once he said, “Yes,” I didn’t focus on the outcome, but rather on the results from each new imaging scan, which subsequently got better as the treatment worked its magic. Each scan showed a reduction in the tumors in my liver and no other signs of metastases, and Jaione and I held onto that improvement in my health and tried not to think too far ahead.

When you don’t know whether the rest of your life will be measured in months, years, or decades, you become more focused on the here and now and what is important in your life. I knew I wanted to give back to the oncology community that had given so much to me. I wrote a book that chronicles the story of my cancer recovery through the focus of my wildlife photography lens, and donated all the proceeds to the Colorectal Cancer Alliance. I also became a patient advocate and have joined the Colorado Cancer Coalition to help accelerate a bill through the Colorado state legislature that would lower the age guideline for insurance coverage for screening colonoscopies from 50 to 45.

Preventing colorectal cancer

My experience with cancer also has led me to look for ways to raise awareness of colorectal cancer, especially in younger adults. I completed a short-term assignment with Fight Colorectal Cancer and served on the national board of the Colorectal Cancer Alliance helping to raise much-needed funding for research, and the work has been very rewarding.

I know my diagnosis of colorectal cancer at a young age puts my children at higher risk for developing the disease. I want to do everything I can to change the potential trajectory of our family history so they never have to hear the words, “You have colorectal cancer.”

I am incredibly fortunate. I’ve been the beneficiary of research advances that have allowed me to surpass the survival odds and of an oncology team that treated me as a partner in all treatment decision-making and never allowed me to give up hope. Because of their efforts, I’ve turned my pain into a new life purpose, and I’m committed to ensuring that every person with colorectal cancer has those same advantages, so they, too, have a chance at living fulfilling lives after cancer. 

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Despite Proven Safety of HPV Vaccines, More Parents Have Concerns

October 22, 2021, by NCI Staff Credit: National Cancer Institute Despite more than 15 years of consistent evidence that HPV vaccines are safe and effective, a...

FDA Approves Atezolizumab as Adjuvant Treatment for Non-Small Cell Lung Cancer

On 15 October 2021, the US Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for adjuvant treatment following resection and platinum-based chemotherapy...

Breast Cancer Survivor Uses Comedy to Spread Awareness and Address Disparities

Suzette Simon lost her mother to breast cancer. In 2020, she learned that she had the disease, as well. Realizing how much harder breast...

Why Wearing Comfortable Clothes During Cancer Treatment Matters

Voices on Cancer is an award-winning Cancer.Net Blog series where advocates share their stories and the lessons they have learned about being a cancer advocate. Cindy Trice is...

Breast cancer surgery: ‘I’m proud of the tattoos inked across my chest’

Wendy had a double mastectomy in 2017 and remained flat. “When the consultant told me, I remember crying and saying that I have 2 young...

EMA Recommends Granting a Marketing Authorisation for Zanubrutinib for the Treatment of Waldenström’s Macroglobulinaemia

On 16 September 2021, the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use adopted a positive opinion, recommending the granting of...